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Rhabdomyosarcoma (RMS) is the most common sarcoma in paediatric patients. A perianal site is unusual and is associated
with a low cure rate. The few cases of reported perianal RMS have been associated with sequelae. Here, we report the case
of a 29-month-old male child who received sequential treatment by surgery, chemotherapy and radiotherapy inspired by
Papillon’s irradiation of adult anal/low-rectum cancers (including external beam radiotherapy in the gynecological exam
position followed by brachytherapy) and who remains in complete remission 49 months post treatment with no sphincter
or other anorectal disorders.
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coma in pediatric patients. A perianal site is unusual and
is associated with high risk and a low cure rate [1]. The
treatment of choice for RMS combines intensive chemo-
therapy, high-dose radiotherapy and complete surgical
excision, but there is no established treatment strategy
for RMS of the perineum or anus, in particularly in the
Intergroup Rhabdomyosarcoma Staging (IRS) reports, as
these locations are rare. The few cases of perianal RMS
that have been reported have been associated with frequent
sphincter disorders or anal ulcerations [2]. Wide first-line
curative surgery is possible but causes loss of sphincter
function. Conservative complete or partial surgery com-
bined with adjuvant chemotherapy and/or radiotherapy
may be considered in Stage 1 disease, care being taken to
avoid dermatitis that might cause problems on subsequent
radiotherapy [2]. This option helps spare sphincter func-
tion without jeopardizing oncological outcome.
However, a cogent multimodal therapeutic approach as
used for anal or lower rectal carcinomas can secure sphinc-
ter preservation. In other situations (prostate, bladder or* Correspondence: charlotte.demoor@ico.unicancer.fr
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article, unless otherwise stated.utero-vaginal), conservative RMS treatment has been
shown to be possible by combining brachytherapy with
surgery [3,4]. Here, we report the case of a 29-month-old
male child who received sequential treatment by surgery,
chemotherapy and a radiotherapy technique inspired by
Papillon’s irradiation of adult anal and low-rectum cancers
[5] (including external beam radiotherapy (EBRT) in the
gynecological exam position followed by brachytherapy)
and who remains in complete remission 49 months post
treatment with no sphincter or other anorectal disorders.Case report
A 29-month-old male with no predisposing personal or
family history was referred to the Surgery Department
after his mother noticed a pararectal enlargement on
bathing her child. MRI revealed a well-delineated het-
erogeneous left perianal mass (18×32×32 mm) with
probable invasion of the external sphincter (no visible
fatty interface), which was removed by finger-assisted
enucleation. Pathology identified an alveolar RMS with
PAX3–FKHR fusion transcript. No residual mass was
visible on MRI. Left perianal hypermetabolism was ob-
served on 18FDG PET-CT with no evidence of disease
extension. A selective dissection of ilioinguinal lymph
nodes visible on the MRI was performed and the patho-
logic analysis revealed no metastasis. According to theioMed Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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III because of the incomplete initial surgery, therefore
necessitating chemotherapy and adjuvant irradiation.
Secondary surgery was avoided because it may have im-
paired the anal sphincter function. The patient received
9 cycles of chemotherapy (ifosfamide, vincristin, actino-
mycin over 2 days every 3 weeks during 7 months) with-
out experiencing any severe adverse events.
The objective of the irradiation treatment was to deliver
the equivalent of 50 Gy to the tumor bed which was de-
fined as the Gross Tumor Volume (GTV) on the initial
MRI. Two margins of 1 cm was applied to obtain respect-
ively the Clinical Target Volume (CTV) and the Planning
Target Volume (PTV) with retrieving 0.4 cm from the skin
(posterior limit). The treatment position was thought to
minimize irradiation to the femoral heads. Therefore, we
decided to combine EBRT and brachytherapy similarly to
the radiotherapy regimen pioneered by Papillon [6]. EBRT
(28.8 Gy in 16 Gy fractions) was delivered during the 5th
cycle (without actinomycin). Brachytherapy started 3 weeks
and 5 days after the last session of EBRT and a few days
before the 7th cycle (also without actinomycin).
For EBRT, the child was placed in the gynecological
exam position [Figure 1A] and immobilized using cus-
tom molded thermal plastic masks without any general
anesthesia since the child was very compliant. EBRT was
delivered with 6 MV photon beams: two direct radiationFigure 1 Radiation therapy. (A) patient positioning for EBRT using custom
2 lateral beams and 2 direct perineal beams; (C and D) dosimetric illustrati
yellow 21 Gy, red 22.05 (105%); C: coronal incidence through the femoral h
brachytherapy (I192) with 3 needles implanted in initial tumor bed.fields (an oblique anterior perineal-sacral field and a
more posterior field at a 65° angle) and two lateral fields
[Figure 1B]. This configuration reduced the radiation
dose to healthy tissue and thus damage to the anus and
femoral heads. We explored alternative techniques such
as Intensity Modulated Radiation Therapy, but this op-
tion was not chosen to avoid low dose distribution to
surrounding perineal tissues. EBRT was well tolerated
without skin or intestinal toxicity.
One month after, low dose rate Iridium-192 interstitial
brachytherapy (specific activity 5.17 μGy/h/m/cm,) was
delivered. Needles were manually loaded with iridium
wires of 35 mm length under general anesthesia. The
technique delivered 21.2 Gy dose in a 5.5 cm3 volume ac-
cording to the Paris system rules corresponding to the ini-
tial volume of the tumor visible on the MRI [Figure 1C].
The child was hospitalized during 4 days and did not re-
quire anesthesia during the brachytherapy application.
Symptomatic treatment was delivered to manage the dis-
comfort of the child and no adverse effect occurred during
the brachytherapy application.
The maximum dose (EBRT + brachytherapy) to the left
and right testicles was 8 Gy (7 + 1) and 1.5 Gy (1 + 0.5), re-
spectively. Mean dose to the bladder was 29 Gy (28 + 1)
and to femoral heads was only 12 Gy.
Overall treatment tolerance, whether gastrointestinal,
cutaneous or mucosal, was satisfactory in the short andmolded thermal plastic masks; (B) ballistics of the 4 treatment beams:
on of the EBRT treatment (green 4 Gy, blue 10 Gy, cyan 20.58 Gy (95%),
eads; D: coronal incidence through the anal spincter (E) low dose rate
Demoor-Goldschmidt et al. Radiation Oncology  (2015) 10:108 Page 3 of 3medium term. Toilet training was not delayed. Height-
weight growth was normal. The child is still in complete
remission 49 months after treatment, and presents no
sphincter disorder or major local sequelae except lim-
ited telangiectasia in the brachytherapy boost region
[Figure 1D]. Long-term follow-up will be required to
monitor remission and detect any late complications.
Discussion
According to the Intergroup RMS Study Group (IRSG)
review of 71 children with perineal or anal RMS from
1972 through to 1997, the prognosis is poor, with a 5-
year failure-free survival rate of only 45% and overall
survival (OS) rate of 49% [4]. No details of the manage-
ment of the radiation therapy are available. The lack of
guidelines is a real difficulty to treat this rare disease.
Median patient age was 6 years, 36% of patients were
misdiagnosed at the time of surgical management, 45%
had an initial biopsy diagnosis, and 64% had advanced
stage disease at initial presentation. Delayed RMS diag-
nosis jeopardizes the chances of a cure [7,8]. A tumor
size less than 5 cm was associated with a better 5-year
OS rate (74% vs 37%).
The challenge for this child was to cure him while
sparing his sphincter. A combination of radiotherapy
techniques including EBRT and brachytherapy according
to the sphincter preservation protocol pioneered by Jean
Papillon at the Centre Léon Bérard (Lyon, France) for
carcinomas of the lower rectum and anal canal [5,9,10]
was easily delivered because of his excellent cooperation.
Papillon treated carcinomas of the lower rectum and
anal canal, with sphincter preservation, by conventional
EBRT (30 Gy by a fixed direct perineal Cobalt-60 beam
to the anus and the pelvic lymphatic drainage areas and
18 Gy by a posterior arc beam with a patient in the
gynecological position). With this method, EBRT was
followed after 2 months rest by Iridium-192 brachyther-
apy that delivered 20 Gy to a limited volume at a dose-
rate of about 10 Gy/day by implanting in the anal
sphincter 5 to 7 needles through a crescent-shaped tem-
plate sutured to the perineal skin. His multimodal treat-
ment was one of the first strategies to suggest that
sphincter preservation in low gastrointestinal tract tu-
mors was achievable with good clinical outcomes.
Conclusion
Perianal RMS are high-risk tumors. Multimodal treat-
ment should be initiated without delay. If possible, ag-
gressive and mutilating first-line surgery should be
avoided as positive surgical margins are common and
postoperative sequelae can hamper subsequent treat-
ment. Multimodal treatment may preserve sphincter
function and achieve remission without major complica-
tions, and should not be withheld because of young age.If parents cooperate and all steps are clearly explained to
the child, a patient positioning best suited to EBRT dos-
imetry can be used and low-dose rate brachytherapy
(nowadays replaced by pulsed dose-rate brachytherapy)
can be delivered over the course of a few days.
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